Min Vedal
About Min Vedal
Min Vedal is a Senior Manager, Biostatistics at Bristol Myers Squibb in Seattle, Washington, with extensive experience in biostatistics and epidemiology across various therapeutic areas and clinical trial phases.
Professional Experience
Min Vedal currently serves as Senior Manager, Biostatistics at Bristol Myers Squibb in Seattle, WA. Previously, he held the position of Principal Biostatistician at IQVIA for two years from 2020 to 2022. From 2016 to 2020, he was Sr. Principal Biostatistician at Chiltern, a Covance company, in the Greater Seattle Area. His prior experience includes brief tenures as a Biostatistician at Sanofi in Bridgewater, NJ, and a Biostatistician at PPD in Beijing, China. Min also worked as a Statistician at Tasly in Tianjin, China, and as a Data Analyst at the University of Washington in Seattle, WA.
Educational Background
Min Vedal pursued extensive academic training in epidemiology and biostatistics. He earned a PhD in Epidemiology and Biostatistics from Tianjin Medical University, where he studied from 2008 to 2011. He also achieved a Master of Science in Epidemiology and Health Statistics from the same institution, completing his studies from 2004 to 2007. Additionally, Min participated in an exchange PhD program at the University of Washington, focusing on Environmental Health, Epidemiology, and Biostatistics from 2009 to 2013.
Skills and Expertise
Min Vedal is proficient in statistical programming, utilizing tools like SAS and R. He has a solid grasp of FDA regulations, ICH GCP guidelines, and the clinical trial process. Min's expertise includes developing study synopses, protocols, statistical analysis plans, and other regulatory documents. He is experienced with NDA submissions to regulatory bodies like the USFDA, EMA, and PMDA using the e-CTD system. His research background encompasses a variety of statistical methods, including multiple linear and logistic regression, relative risk regression, multivariate methods, and survival analysis.
Regulatory and Clinical Trial Experience
Min Vedal has significant experience in the biostatistical facets of clinical trials across various therapeutic areas, such as oncology, rare disease, cardiovascular disease, dermatology, immunology, respiratory disease, anti-viral medicine, and diabetes. He has been involved in all phases of clinical trials (Phase I-IV) and provides comprehensive statistical input for study designs, analyses, and interpretation of clinical data. Min has prepared regulatory submissions and contributed to the development of biopharmaceutical products, ensuring compliance with statistical standards and guidelines.
Language Proficiency and Communication
Min Vedal is bilingual, fluent in English and Mandarin Chinese. This linguistic capability enhances his ability to collaborate with international teams and contributes to his effectiveness in global regulatory and clinical trial environments. His communication skills support his role in cross-functional teams, facilitating accurate and reliable biostatistical data collection and analysis in collaborative research settings.